Related references
Note: Only part of the references are listed.Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
Stephen T. Oh et al.
BLOOD (2010)
CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms
Jeffrey W. Tyner et al.
BLOOD (2010)
JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia
Juan Li et al.
BLOOD (2010)
Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
Ann Mullally et al.
CANCER CELL (2010)
TLR8-dependent TNF-α overexpression in Fanconi anemia group C cells
Scott M. Vanderwerf et al.
BLOOD (2009)
CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients
A. Pardanani et al.
LEUKEMIA (2009)
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
Amy V. Jones et al.
NATURE GENETICS (2009)
JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science
O. Kilpivaara et al.
LEUKEMIA (2008)
TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells
June Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations
A. Pardanani et al.
LEUKEMIA (2007)
Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice
Daniel P. Sejas et al.
JOURNAL OF IMMUNOLOGY (2007)
Mechanisms of disease: The myeloproliferative disorders
Peter J. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Characterization of murine JAK2V617F-positive myeloproliferative disease
Thomas G. P. Bumm et al.
CANCER RESEARCH (2006)
Pathogenesis of myelofibrosis with myeloid metaplasia
A Tefferi
JOURNAL OF CLINICAL ONCOLOGY (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Tumor necrosis factor alpha induces senescence and chromosomal instability in human leukemic cells
O Beyne-Rauzy et al.
ONCOGENE (2004)
TNF-α and IFN-γ are overexpressed in the bone marrow of Fanconi anemia patients and TNF-α suppresses erythropoiesis in vitro
C Dufour et al.
BLOOD (2003)
Signalling pathways of the TNF superfamily: A double-edged sword
BB Aggarwal
NATURE REVIEWS IMMUNOLOGY (2003)
Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation
D Bryder et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells
I Dybedal et al.
BLOOD (2001)
Share Paper
